Navigation Links
Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
Date:8/19/2007

BASINGSTOKE, England and PHILADELPHIA, August 15 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces that the waiting period under Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to its exclusive license of JUVISTA(R) (human TGF BETA 3) from Renovo Group plc (LSE: RNVO) expired on August 10, 2007. In accordance with its terms, the License Agreement became effective on August 15, 2007.

JUVISTA is a novel biopharmaceutical investigational drug and when injected at the time of surgery has been shown in clinical trials to markedly improve subsequent scar appearance in the skin.

Under the terms of the agreement, Shire has the exclusive right to commercialize JUVISTA worldwide, with the exception of EU member states. Shire's financial obligations under the agreement are geared to JUVISTA's successful development and commercialization. Shire will now pay Renovo US$75 million upfront (expensed during the third quarter as R&D for US GAAP purposes) and in addition, Shire will make an equity investment in Renovo of US$50 million (at a subscription price of GBP2 per share, which represents approximately 6.5% of Renovo's share capital immediately after the issue).

On the FDA's acceptance of filing of JUVISTA's biologics license application, Shire will pay US$25 million and on FDA approval, between US$50 and US$150 million depending on the characteristics of the approved product labelling. Shire will also pay Renovo royalties on sales of JUVISTA and milestone payments of up to US$525 million on the achievement of very significant sales targets.

Notes to Editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestina
'/>"/>

SOURCE Shire PLC

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Im Still Waiting for the Information Age in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... (PRWEB) May 22, 2013 Oven Industries ... with the integrated potentiometers or via a PC through ... measuring two and one half inches square can deliver ... zero voltage switched, low noise solid state relay. Operator ... isolation for the communication port and sensor input. ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
(Date:5/22/2013)... 2013 The Conference Forum ... to Advance Clinical Trials conference taking place on September ... MA. , Disruptive thinkers from Novartis, Pfizer, Eli ... bold approaches to reduce expensive infrastructure, engage patients and ... to be big, or novel, or it must change ...
(Date:5/22/2013)... May 22, 2013  Empire Genomics announced today ... patent pending novel genomic biomarker from Cornell University ... that could help in diagnosing and determining treatment ... Neuroendocrine prostate cancer (NEPC) is a ... arise de novo, but more commonly arises after ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Nov. 20 Wyeth (NYSE: WYE ... been promoted to President,Technical Operations & Product Supply ... aspects of technical operations and product supply for,Wyeth, ... units. He succeeds Charles Portwood, 58, who ...
... meeting of the Board,of Directors of Wyeth (NYSE: ... share on the outstanding shares of Preferred Stock was declared,payable ... close of business,on December 12, 2008. , ... research-driven pharmaceutical and,health care products companies. It is a ...
... Inc.,(Nasdaq: HOLX ), a leading developer, manufacturer ... products dedicated to,serving the healthcare needs of women, today ... the investment community who will be attending the RSNA,(Radiological ... This meeting will ...
Cached Biology Technology:Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2
(Date:5/21/2013)... concept of "place" is increasingly being considered in ... have a new resource that can help them ... with the places in their lives. , ... new book co-edited by the Pacific Northwest Research ... human-centered approach to conservation. The book is published ...
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
(Date:5/21/2013)... University of Michigan Water Center today awarded 12 ... Lakes restoration and protection efforts. , The two-year ... projects, including efforts to track the remediation of ... to control non-native weedy plant invasions; study chromosomal ... responses to restoration activities. , The grants were ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... more allergies one has, the lower the risk of ... in Cancer Epidemiology, Biomarkers & Prevention , a ... Researchers from the University of Illinois at Chicago, used ... for 419 patents with glioma and 612 cancer-free patients ...
... gibbons (genus Nomascus ) live in dense Asian rainforest, ... their environment, they communicate with other gibbons by singing. Both ... find a mate, and couples also sing duets to strengthen ... access journal BMC Evolutionary Biology describes how gibbon ...
... An international team of researchers has made new links between ... common form of inflammatory bowel disease (IBD). The new findings ... associated with inflammatory bowel disease to 99. The results ... bodies maintain the lining of the intestinal wall, which are ...
Cached Biology News:Allergies lower risk of low- and high-grade glioma 2Research links 29 genome regions with common form of inflammatory bowel disease 2Research links 29 genome regions with common form of inflammatory bowel disease 3
... AvoidanceIncludes all features of Tracker, plus software to ... defined subsection of the arena, and trigger a ... instruments all built around a video camera, frame ... track two fields at once and up to ...
... ACS Reagent Grade C 19 H 9 ... 691.95 PRODUCT SPECIFICATIONS Form: Powder Clarity of ... pH 3.0 - Yellow pH 4.6 ... dye in agarose and acrylamide gel electrophoresis. ...
... innovation from Magnetofection technology, SilenceMag is ... available. Simple, rapid and easy to ... non toxic. Specifically designed for siRNA ... at very low doses of siRNA.,SilenceMag ...
... Software reads and processes raw ... microarray data for analysis. ... one 1-year license for Feature ... ,one CD-ROM containing Feature Extraction ...
Biology Products: